| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/22/2010 | WO2010044401A1 Morpholinopurine derivative |
| 04/22/2010 | WO2010044390A1 Viral infection therapeutic drug containing polyalkyleneimine |
| 04/22/2010 | WO2010044371A1 Insulin secretion stimulator |
| 04/22/2010 | WO2010044108A2 Controlled release formulations of ropinirole |
| 04/22/2010 | WO2010044103A1 Pharmaceutical composition for therapeutic or prophylactic treatment of bacterial infections and associated diseases |
| 04/22/2010 | WO2010044097A2 Novel dosage form of paliperidone and process for preparing the same |
| 04/22/2010 | WO2010044094A2 A topical composition for the treatment of erectile dysfunction |
| 04/22/2010 | WO2010044093A1 Formulations containing rifaximin |
| 04/22/2010 | WO2010044089A1 Drug delivery system for econazole, moxifloxacin, and rifampicin |
| 04/22/2010 | WO2010044085A1 Compositions and methods for treating varicose veins |
| 04/22/2010 | WO2010044070A2 Synergistic composition for recovery and reduction of mild ischemic damage |
| 04/22/2010 | WO2010044054A1 Phenethylamide derivatives and their heterocyclic analogues |
| 04/22/2010 | WO2010044042A1 Antimicrobial compositions |
| 04/22/2010 | WO2010044016A1 Novel uses for esreboxetine and racemic reboxetine |
| 04/22/2010 | WO2010043981A1 Method for treatment of copd and other pulmonary diseases |
| 04/22/2010 | WO2010043976A2 Highly pure ranolazine or a pharmaceutically acceptable salt thereof |
| 04/22/2010 | WO2010043972A2 Pharmaceutical compositions and methods of use for the prevention and treatment of hypoxic injury |
| 04/22/2010 | WO2010043950A2 Propafenone extended release composition |
| 04/22/2010 | WO2010043893A1 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
| 04/22/2010 | WO2010043880A1 Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases |
| 04/22/2010 | WO2010043867A1 Pyrrolo [2, 3-d] pyrimidines as inhibitors of hsp90 |
| 04/22/2010 | WO2010043866A2 Histone lysine demethylase inhibitors |
| 04/22/2010 | WO2010043865A1 Inhibitors of hsp90 |
| 04/22/2010 | WO2010043832A1 Novel pharmaceutical uses for nanoparticles |
| 04/22/2010 | WO2010043787A1 Use of 4-(3-[hexahydrocyclopenta[c]pyrrol-i(1h)-yl]propoxy}benzamide for making drugs for treating sleep disorders |
| 04/22/2010 | WO2010043749A1 Composition for treatment of metabolic syndrome |
| 04/22/2010 | WO2010043748A1 Biosynthesis of derivatives of monacolin j |
| 04/22/2010 | WO2010043721A1 Oxidase inhibitors and their use |
| 04/22/2010 | WO2010043717A2 Pharmaceutical topical compositions |
| 04/22/2010 | WO2010043714A1 Tricyclic nitrogen compounds used as antibacterials |
| 04/22/2010 | WO2010043711A1 Allosteric protein kinase modulators |
| 04/22/2010 | WO2010043688A1 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug |
| 04/22/2010 | WO2010043676A1 Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (pi3-kinases) inhibitor |
| 04/22/2010 | WO2010043633A1 2h-pyrazolo [4,3-d]pyrimidin-5-amine derivatives as h4 histamine receptor antagonists for the treatment of allergic, immunological and inflammatory diseases |
| 04/22/2010 | WO2010043631A1 Di-vanilloyl and tri-vanilloyl derivatives for use in anti-cancer therapy |
| 04/22/2010 | WO2010043606A1 Long-term stable microbicide and coating for preventing biofilm formation and coating composition therefor |
| 04/22/2010 | WO2010043601A1 Process for the preparation of enantiomerically enriched proton pump inhibitors |
| 04/22/2010 | WO2010043592A1 Lipase inhibitors for use for the treatment of obesity |
| 04/22/2010 | WO2010043584A1 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors |
| 04/22/2010 | WO2010043561A2 Regenerative therapy |
| 04/22/2010 | WO2010043550A1 Use of dianhydrohexite mononitrate derivatives as healing agents |
| 04/22/2010 | WO2010043539A1 Novel oxadiazolyl-diazabicyclononane derivatives and their medical use |
| 04/22/2010 | WO2010043513A1 New benzimidazole derivatives |
| 04/22/2010 | WO2010043444A2 Pharmaceutical preparation for the treatment and/or prevention of ischemia/reperfusion injury and the sequels thereof |
| 04/22/2010 | WO2010043412A1 Co-crystals of tramadol and nsaids |
| 04/22/2010 | WO2010043408A2 Microencapsulated fesoterodine |
| 04/22/2010 | WO2010043396A1 Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
| 04/22/2010 | WO2010043377A1 New 2-amidothiadiazole derivatives |
| 04/22/2010 | WO2010043376A1 Tablet containing valsartan |
| 04/22/2010 | WO2010043240A1 Administration scheme of polar opioid metabolites for post-operative pain management |
| 04/22/2010 | WO2010043186A1 New pt(ii) complex and antitumor activity thereof |
| 04/22/2010 | WO2010043180A1 Ethoxy diphenyl ethane derivates, preparation processes and uses thereof |
| 04/22/2010 | WO2010043156A1 Drop pill for treating coronary heart disease and preparation thereof |
| 04/22/2010 | WO2010043155A1 Novel purpurone-type alkaloids, process for their preparation, and their usage as medications |
| 04/22/2010 | WO2010043109A1 The use of corynantheine in preparation of medicaments for treating myocardial damage heart disease |
| 04/22/2010 | WO2010043052A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/22/2010 | WO2010043050A1 Combinations of a liposomal water-soluble camptothecin with cetuximab or bevacizumab |
| 04/22/2010 | WO2010043049A1 Etoposide and doxorubicin conjugates for drug delivery |
| 04/22/2010 | WO2010043029A1 Use of tetrose to inhibit cancer and to increase cell viability |
| 04/22/2010 | WO2010043010A1 N-acyl hydrazine derivatives, method for producing n-acyl hydrazine compounds, pharmaceutical compositions containing same, uses thereof and methods for treatment |
| 04/22/2010 | WO2010043000A1 S1p receptors modulators and their use thereof |
| 04/22/2010 | WO2010042998A1 S1p receptors modulators |
| 04/22/2010 | WO2010042991A1 Methods of treatment utilising glucan formulations |
| 04/22/2010 | WO2010025308A3 Inhibitors of dutpase |
| 04/22/2010 | WO2010023725A9 Novel compound signamycin, method for production thereof, and use thereof |
| 04/22/2010 | WO2010022380A3 Linear polyol stabilized polyfluoroacrylate compositions |
| 04/22/2010 | WO2010022236A3 Inhibiting obesity progression by inhibiting adipocyte differentiation with a pre-adipocyte autophagy inhibitor |
| 04/22/2010 | WO2010018113A3 Bi-aryl aminotetralines |
| 04/22/2010 | WO2010018112A3 Monoaryl aminotetralines |
| 04/22/2010 | WO2010016931A3 Polymorphs of fluticasone furoate and process for preparation thereof |
| 04/22/2010 | WO2010014613A3 Treating various disorders using trkb agonists |
| 04/22/2010 | WO2010014172A3 Delivery particle |
| 04/22/2010 | WO2010012904A3 Novel cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method |
| 04/22/2010 | WO2010012466A8 Antitumor properties of no modified protease inhibitors |
| 04/22/2010 | WO2010011922A3 Novel crystalline salts of epalrestat |
| 04/22/2010 | WO2010011917A8 sEH AND 11β-HSD1 DUAL INHIBITORS |
| 04/22/2010 | WO2010011879A3 Methods and compositions for treating and preventing autoimmune diseases |
| 04/22/2010 | WO2010011864A3 Alpha-helix mimetic with functionalized pyridazine |
| 04/22/2010 | WO2010011666A3 Indoline scaffold shp-2 inhibitors and cancer treatment method |
| 04/22/2010 | WO2010011325A3 Synthesis and utilization of small molecules for the treatment of inflammation associated with interleukin-1 signaling |
| 04/22/2010 | WO2010011318A3 Activatiqn of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival |
| 04/22/2010 | WO2010011296A3 Deacetylase inhibitors and uses thereof |
| 04/22/2010 | WO2010009985A3 Therapeutic combination comprising an aurora kinase inhibitor and antiproliferative agents |
| 04/22/2010 | WO2010009120A3 Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents |
| 04/22/2010 | WO2010009116A3 Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents |
| 04/22/2010 | WO2010008739A3 Aryl gpr119 agonists and uses thereof |
| 04/22/2010 | WO2010008474A3 Methods for treating multiple sclerosis using antisense oligonucleotides |
| 04/22/2010 | WO2010008224A3 Fast-dissolving amlodipine tablets of improved stability and a method of manufacture thereof |
| 04/22/2010 | WO2010007332A3 Composition of branched maltodextrins and eukaryotic organisms having a polysaccharide wall, used in the field of well-being |
| 04/22/2010 | WO2010006153A3 Topopyrones: dual topoisomerase inhibitors |
| 04/22/2010 | WO2010006130A3 Pde-10 inhibitors |
| 04/22/2010 | WO2010005726A3 Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same |
| 04/22/2010 | WO2010005725A3 Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same |
| 04/22/2010 | WO2010005580A3 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 04/22/2010 | WO2010005528A3 Pyrrolopyridine carboxylic acid derivatives |
| 04/22/2010 | WO2010003624A3 Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| 04/22/2010 | WO2010003313A8 Icotinib hydrochloride, synthesis, crystallographic form, medical combination, and uses thereof |
| 04/22/2010 | WO2009158309A3 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 04/22/2010 | WO2009156680A3 Combination of a nicotinic receptor partial agonist and of an acetylcholinesterase inhibitor, pharmaceutical composition containing same and use thereof in the treatment of cognitive disorders |
| 04/22/2010 | WO2009155535A3 Compositions, methods and kits for eliciting an immune response |